Ratliff KS - Search Results

1

Protein unfolding by the mitochondrial membrane potential.

Huang S, Ratliff KS, Matouschek A. Huang S, et al. Among authors: ratliff ks. Nat Struct Biol. 2002 Apr;9(4):301-7. doi: 10.1038/nsb772. Nat Struct Biol. 2002. PMID: 11887183

2

An unstructured initiation site is required for efficient proteasome-mediated degradation.

Prakash S, Tian L, Ratliff KS, Lehotzky RE, Matouschek A. Prakash S, et al. Among authors: ratliff ks. Nat Struct Mol Biol. 2004 Sep;11(9):830-7. doi: 10.1038/nsmb814. Epub 2004 Aug 15. Nat Struct Mol Biol. 2004. PMID: 15311270

3

Mitochondria unfold precursor proteins by unraveling them from their N-termini.

Huang S, Ratliff KS, Schwartz MP, Spenner JM, Matouschek A. Huang S, et al. Among authors: ratliff ks. Nat Struct Biol. 1999 Dec;6(12):1132-8. doi: 10.1038/70073. Nat Struct Biol. 1999. PMID: 10581555

4

Active unfolding of precursor proteins during mitochondrial protein import.

Matouschek A, Azem A, Ratliff K, Glick BS, Schmid K, Schatz G. Matouschek A, et al. EMBO J. 1997 Nov 17;16(22):6727-36. doi: 10.1093/emboj/16.22.6727. EMBO J. 1997. PMID: 9362487 Free PMC article.

5

Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels.

Swensen AM, Herrington J, Bugianesi RM, Dai G, Haedo RJ, Ratliff KS, Smith MM, Warren VA, Arneric SP, Eduljee C, Parker D, Snutch TP, Hoyt SB, London C, Duffy JL, Kaczorowski GJ, McManus OB. Swensen AM, et al. Among authors: ratliff ks. Mol Pharmacol. 2012 Mar;81(3):488-97. doi: 10.1124/mol.111.075226. Epub 2011 Dec 21. Mol Pharmacol. 2012. PMID: 22188924

6

Identification of novel and selective Kv2 channel inhibitors.

Herrington J, Solly K, Ratliff KS, Li N, Zhou YP, Howard A, Kiss L, Garcia ML, McManus OB, Deng Q, Desai R, Xiong Y, Kaczorowski GJ. Herrington J, et al. Among authors: ratliff ks. Mol Pharmacol. 2011 Dec;80(6):959-64. doi: 10.1124/mol.111.074831. Epub 2011 Sep 26. Mol Pharmacol. 2011. PMID: 21948463

7

A KV2.1 gating modifier binding assay suitable for high throughput screening.

Schmalhofer WA, Ratliff KS, Weinglass A, Kaczorowski GJ, Garcia ML, Herrington J. Schmalhofer WA, et al. Among authors: ratliff ks. Channels (Austin). 2009 Nov;3(6):437-47. doi: 10.4161/chan.3.6.10201. Channels (Austin). 2009. PMID: 21150283 Free article.

8

An automated electrophysiology serum shift assay for K(V) channels.

Ratliff KS, Petrov A, Eiermann GJ, Deng Q, Green MD, Kaczorowski GJ, McManus OB, Herrington J. Ratliff KS, et al. Assay Drug Dev Technol. 2008 Apr;6(2):243-53. doi: 10.1089/adt.2008.128. Assay Drug Dev Technol. 2008. PMID: 18471078

9

A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.

Dai G, Haedo RJ, Warren VA, Ratliff KS, Bugianesi RM, Rush A, Williams ME, Herrington J, Smith MM, McManus OB, Swensen AM. Dai G, et al. Among authors: ratliff ks. Assay Drug Dev Technol. 2008 Apr;6(2):195-212. doi: 10.1089/adt.2008.136. Assay Drug Dev Technol. 2008. PMID: 18471074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters